Page last updated: 2024-08-16

rivastigmine and ketamine

rivastigmine has been researched along with ketamine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Budni, J; de Oliveira, MB; Deroza, PF; Fraga, DB; Heylmann, AS; Julião, RF; Luca, RD; Pacheco, FD; Quevedo, J; Volpato, AM; Zugno, AI	1

Reviews

1 review(s) available for rivastigmine and ketamine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for rivastigmine and ketamine

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia. Metabolic brain disease, 2013, Volume: 28, Issue:3 Topics: Acetylcholinesterase; Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Brain; Cholinesterase Inhibitors; Cognition Disorders; Electroshock; Excitatory Amino Acid Antagonists; Ketamine; Male; Memory; Memory, Short-Term; Motor Activity; Neuroprotective Agents; Phenylcarbamates; Rats; Rats, Wistar; Rivastigmine; Schizophrenia; Schizophrenic Psychology	2013

Article

Year

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.

Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008

Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.

Metabolic brain disease, 2013, Volume: 28, Issue:3

Topics: Acetylcholinesterase; Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Brain; Cholinesterase Inhibitors; Cognition Disorders; Electroshock; Excitatory Amino Acid Antagonists; Ketamine; Male; Memory; Memory, Short-Term; Motor Activity; Neuroprotective Agents; Phenylcarbamates; Rats; Rats, Wistar; Rivastigmine; Schizophrenia; Schizophrenic Psychology

2013